Early predictive value of plasma biomarkers for amyloid positivity

Predicting amyloid PET and tau PET stages with plasma biomarkersПодробнее

Diagnostic performance of plasma p-tau217 in a memory clinic cohortПодробнее

Biomarkers for risk assessment and early diagnosis of ADПодробнее

Alzheimer’s Disease 2024: The Role of BiomarkersПодробнее

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s diseaseПодробнее

The value of plasma p-tau181 as a screening and diagnostic tool for Alzheimer’s diseaseПодробнее

Plasma biomarkers for Alzheimer's disease as pre-screening toolsПодробнее

Using plasma biomarkers in the diagnosis of Alzheimer’s diseaseПодробнее

Plasma p-tau as a biomarker for cerebral amyloid angiopathy diagnosisПодробнее

Alzheimer’s disease plasma biomarkers across the spectrum: which perform best?Подробнее

Fluid Biomarkers in Dementia: An Update - Clinical Core Webinar - April 23, 2021Подробнее

Prognostic value of plasma biomarkers GFAP and pTau181 for all-cause and Alzheimer’s dementiaПодробнее

The potential of plasma biomarkers in dementiaПодробнее

Blood-based biomarkers as surrogates of amyloid burden in preclinical Alzheimer's diseaseПодробнее

Early Detection, Better Direction: Tau Biomarkers and Amyloid-Targeting Therapies in Alzheimer’sПодробнее

Molecular Biomarkers of Neurodegeneration - Ace Global Research Summit 2021Подробнее

Professor Chris Rowe -ADNet and Neuro Imaging & Other BiomarkersПодробнее

Applying Fluid Biomarkers to Facilitate the Accurate Neuropathological Diagnosis of ADПодробнее

Biomarkers for early detection of Alzheimer’s disease: microRNAsПодробнее